missing translation for 'onlineSavingsMsg'
Learn More
Learn More
(2S,3S)-3-(Boc-amino)-1,2-epoxy-4-phenylbutane, 98%, Thermo Scientific™
Description
This Thermo Scientific brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific.
Applications
It function as a building block employed in the synthesis of HIV-1 protease inhibitors and is also employed in synthesizing (hydroxyethyl)urea peptidomimetrics and arylsulfonamides possessing anti-HIV activity. It is a Enantiomer S. Atazanavir intermediate.
Solubility
Insoluble in water. Soluble in Chloroform, Dichloromethane and Ethyl Acetate.
Notes
Store in a cool dry place. Incompatible with oxidizing agents. Keep container tightly closed.
It function as a building block employed in the synthesis of HIV-1 protease inhibitors and is also employed in synthesizing (hydroxyethyl)urea peptidomimetrics and arylsulfonamides possessing anti-HIV activity. It is a Enantiomer S. Atazanavir intermediate.
Solubility
Insoluble in water. Soluble in Chloroform, Dichloromethane and Ethyl Acetate.
Notes
Store in a cool dry place. Incompatible with oxidizing agents. Keep container tightly closed.
Specifications
Specifications
| Melting Point | 125°C to 127°C |
| Quantity | 250 mg |
| UN Number | UN3077 |
| Solubility Information | Insoluble in water. Soluble in Chloroform,Dichloromethane and Ethyl Acetate. |
| Optical Rotation | −71° (c=0.6 in Methanol) |
| Formula Weight | 263.34 |
| Percent Purity | 98% |
| Chemical Name or Material | (2S,3S)-3-(Boc-amino)-1,2-epoxy-4-phenylbutane |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?